Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dizal Pharma
Biotech
Taiho and Cullinan secure lung cancer victory to challenge J&J
Taiho and Cullinan racked up a second phase 3 victory for their EGFR inhibitor, teeing up the partners to challenge J&J in the lung cancer niche.
Nick Paul Taylor
Aug 13, 2026 6:00am
Fierce Pharma
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
ASH: AZ spinout Dizal explores FDA path, US partner for PTCL med
Dec 11, 2023 4:30am
Scoop: Dizal planning U.S. phase 3 NSCLC study in 2022
Sep 12, 2022 7:15am
